Recombinant microorganisms comprising NADPH dependent enzymes and methods of production therefor
The invention provides a recombinant carboxydotrophic Clostridia microorganism with increased overall utilization of NADPH relative to a parent microorganism. Further, the invention provides a method of producing a recombinant carboxydotrophic Clostridia microorganism which exhibits increased NADPH utilization relative to a parental microorganism. In particular, the invention relates to increasing the overall utilization of NADPH in a recombinant carboxydotrophic Clostridia microorganism in order to increase the production of at least one fermentation product by the microorganism.
1. A recombinant Clostridium bacterium adapted to express at least one exogenous nicotinamide adenine dinucleotide phosphate (NADPH)-dependent enzyme.
2. The bacterium of claim 1 , wherein the NADPH-dependent enzyme is a hydrogenase, a formate dehydrogenase, a methylene-tetrahydrofolate (THF)-dehydrogenase, a hydroxymethylglutaryl (HMG)-CoA reductase, a 3-hydroxybutyryl-CoA dehydrogenase, an acetoacetyl-CoA reductase, a trans-2-enoyl-CoA reductase, a nicotinamide adenine dinucleotide (NADH)/nicotinamide adenine dinucleotide phosphate (NADPH) co-dependent enzyme, or a NADH/NADPH bifurcating enzyme.
3. The bacterium of claim 2 , wherein the hydrogenase is a bifurcating nicotinamide adenine dinucleotide phosphate (NADP) Fe-only hydrogenase.
4. The bacterium of claim 2 , wherein the formate dehydrogenase is a bifurcating NADP formate dehydrogenase.
5. The bacterium of claim 2 , wherein the acetoacetyl-CoA reductase is phaB (EC 1.1.1.36).
6. The bacterium of claim 5 , wherein the bacterium further comprises exogenous 3-hydroxybutyryl-CoA dehydratase phaJ (EC 4.2.1.119).
7. The bacterium of claim 5 , wherein the bacterium further comprises exogenous NADH-dependent 3-hydroxybutyryl-CoA dehydrogenase hbd (EC 1.1.1.157).
8. The bacterium of claim 2 , wherein the trans-2-enoyl-CoA reductase is a crotonyl-CoA reductase (also known as butyryl-CoA dehydrogenase).
9. The bacterium of claim 8 , wherein the crotonyl-CoA reductase is ccr (EC 1.3.1.86) or ccr Rs (EC 1.3.1.85).
10. The bacterium of claim 9 , wherein the bacterium further comprises exogenous NADH-dependent crotonyl-CoA reductase (also known as butyryl-CoA dehydrogenase) ter (EC 1.3.1.44).
11. The bacterium of claim 1 , wherein bacterium has increased utilization of NADPH compared to a parental bacterium.
12. The bacterium of claim 1 , wherein bacterium has increased production of at least one fermentation product compared to a parental bacterium.
13. The bacterium of claim 1 , wherein a NADH-dependent isoform of the NADPH-dependent enzyme is attenuated or knocked out compared to a parental bacterium.
14. The bacterium of claim 1 , wherein the bacterium is a carboxydotrophic bacterium.
15. The bacterium of claim 1 , wherein the bacterium is derived from a parental bacterium selected from the group consisting of Clostridium autoethanogenum, Clostridium ljungdahlii, Clostridium ragsdahlei, Clostridium carboxidivorans, Clostridium drakei, Clostridium scatologenes, Clostridium aceticum, Clostridium, formicoaceticum , and Clostridium magnum.
16. The bacterium of claim 15 , wherein the Clostridium autoethanogenum is Clostridium autoethanogenum DSM23693.